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Abstract: Low vitamin D intake and status have been reported worldwide and many 
studies have suggested that this low status may be involved in the development of several 
chronic diseases. There are a limited number of natural dietary sources of vitamin D 
leading to a real need for alternatives to improve dietary intake. Enhancement of foods 
with vitamin D is a possible mode for ensuring increased consumption and thus improved 
vitamin D status. The present review examines studies investigating effects of vitamin D 
enhanced foods in humans and the feasibility of the approach is discussed. 
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1. Introduction 
Vitamin D generally refers to two fat soluble prohormones, ergocalciferol (vitamin D2) and 
cholecalciferol (vitamin D3). Vitamin D2 is produced by certain invertebrates and fungi whilst 
vitamin D3 is produced in the skin of vertebrates, both following exposure to ultraviolet (UV) 
radiation. Ingested vitamin D2 and endogenously produced D3 are converted to the biologically active 
form, 1,25-dihydroxyvitamin D [1,25(OH)2D] (calcitriol) in the human body.  
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Vitamin D is responsible for a wide range of functions in the body and these known roles are 
expanding as research in this field accumulates. The discovery in 1969 of the nuclear vitamin D 
receptor (VDR) for 1,25(OH)2D stimulated a vast amount of research that to date has collectively 
described the presence of the VDR in at least 38 human tissues and organs [1]. The VDR was first 
described in the bone, kidney and gastrointestinal tract but since has been identified in a diverse range 
of other tissues including those in the brain, breast, colon and prostate. The VDR, a phosphoprotein, 
facilitates the various biological functions of calcitriol by binding to the active hormone with high 
affinity and regulating the expression of genes via zinc finger-mediated DNA binding and   
protein–protein interactions [2].  
The well established functions of vitamin D relate to calcium absorption and homeostasis, with  
the role for vitamin D in bone mineralization and bone health extensively documented and long 
recognised, particularly in relation to rickets and osteomalacia [3,4]. Vitamin D, in tandem with 
calcium, may also be involved in the prevention of osteoporosis, fracture incidence and falls, 
particularly in older populations [5,6]. However, vitamin D is no longer regarded as just a calcaemic 
hormone as a result of the widespread distribution of the VDR and the fact that the consequences of 
insufficiency have been shown to extend beyond the above classic effects. Though the evidence is less 
robust, vitamin D deficiency is now implicated in a host of other diseases including psoriasis, multiple 
sclerosis, inflammatory bowel disease, type 1 and 2 diabetes, hypertension, cardiovascular disease, the 
metabolic syndrome and various cancers [7,8]. A thorough examination of all these functions is beyond 
the scope of the present review and the reader is referred to a number of good quality reviews [7,9].  
In parallel with the growing evidence for widespread action for vitamin D there is robust data 
demonstrating that an increased vitamin D status is linked to significant benefits in terms of morbidity 
and mortality risk reduction. A recent review demonstrated that an estimated 20% reduction of global 
vitamin D-sensitive disease mortality and up to 17.6% of all-cause mortality could be achieved by 
doubling vitamin D status [10]. In Nordic populations improvement of vitamin D status may decrease 
the risk of mortality from a number of common diseases including cancer and cardiovascular disease 
between 19 and 24%, depending on the country [10]. For Canada, which shares a similar northerly 
latitude, reductions of 16.1% were estimated [11]. These findings corroborate those of a number of 
other studies that have demonstrated that mortality is greatest amongst individuals with the lowest 
vitamin D status [12,13].  
Taking into account the multiple functions of vitamin D and the disease risk-reduction potential, it 
has become evident that maintaining an adequate status is important. Vitamin D status is assessed by 
measuring the circulating form of the vitamin (25(OH)D) in serum. There is much debate in the 
literature as to which cut-offs to use for defining vitamin D deficiency. However, recent research has 
lead investigators to increase the cut-off for deficiency to 50 nmol/L (from 25 nmol/L). Concomitant 
with this, serum concentrations of 75 nmol/L or higher have been established as adequate levels, with 
values in between indicating insufficiency [14–16]. 
Estimates of global vitamin D status indicate widespread inadequacy, with severe hypovitaminosis D 
most common in the Middle East and South Asia [15]. Even within Europe, large variance in serum 
concentrations exist between countries [17]. Though individuals living at higher latitudes commonly 
exhibit low 25(OH)D serum concentrations due to reduced UVB radiation, especially during winter 
months [18–20], high levels of inadequacy have also been found in Southern Europe, particularly Nutrients 2011, 3  1025 
 
among older populations [21,22]. In the UK, estimates suggest that only 18% and 24.1% of women 
and men, respectively, have adequate 25(OH)D concentrations [19]. Higher 25(OH)D levels have been 
reported in Canada, where 35% of the population have levels above 75 nmol/L [23]. In the US, 58.4% and 
27% of adults have serum 25(OH)D concentrations >50 nmol/L and >75 nmol/L, respectively [24,25].  
Stemming from the reports of low levels of circulating 25(OH)D, certain countries recommend an 
exposure of 10–15 min daily of sunshine [26,27]. However, due to geographical, cultural and 
behavioural differences between populations, increased UVB radiation exposure is not sufficient to 
maintain healthy vitamin D levels, especially during winter. Therefore, optimal dietary vitamin D 
intake is crucial to maintain adequate vitamin D status. The recommendation for vitamin D intake 
differs between countries in Europe and ranges from 0 to 15 µg for different population groups [28]. 
According to a recent report of the Institute of Medicine, the RDA for vitamin D should be 15 µg/day 
for children greater than 1 year old and adults, and 20 µg/day for the elderly [29]. As such, there is a 
renewed interest in improving dietary intake in an effort to meet these recommendations. Additionally, 
if we are to counteract population level vitamin D deficiency enhancement of dietary intake is the only 
feasible mode. 
The main objective of the present review is to provide an overview of the vitamin D containing 
foods available, to include natural, fortified and enriched sources. It will describe the randomized 
controlled trials that have been performed with vitamin D enhanced foods and the effectiveness of 
these in raising serum 25(OH)D levels. The current regulations governing the addition of vitamin D to 
foods in Europe will also be outlined.  
2. Food Intakes and Sources of Vitamin D 
A recent trans-European examination of nutrient intake patterns showed dietary intakes of vitamin D 
to differ markedly between countries. Intakes were significantly higher in Nordic countries including 
Sweden, Denmark and Norway than in Mediterranean regions such as Italy and France [30]. Intakes of 
less than 3.0 µg/day and 2.0 µg/day have been reported in Italian and Spanish adults [31,32]. Older 
men in Finland have some of the highest dietary intakes in Europe at 9.0 µg/day [33]. Recent estimates 
from Ireland revealed intakes ranging from 3.9 µg to 8.5 µg/day in adults, with an increase observed 
with age [34]. In the US, mean dietary consumption for adults ranges from 3.6 to 5.6 µg/day [35], 
lower than the population mean of 5.8 µg/day in Canada [36]. Intakes in Japanese adults appear higher, 
at >6 µg of vitamin D per 1000 kilocalories of energy intake per day [37].  
Foods that make the highest contribution to dietary intakes of vitamin D vary from country to 
country according to habitual dietary patterns. In Norway, the predominant food sources are fish and 
fats [38], as is the case in Finland where liquid milk and dairy products also contribute significantly [33].  
In the UK, oily fish (24%), followed by meat and meat products (22%) and cereal and cereal products 
(21%) contribute the highest percentage to average daily vitamin D intakes in adults [39]. For Irish 
adults, meat (30%), fish (12%) and spreads (10%) made the most significant contributions of all food 
groups [34]. In Spain the main source is fish which accounts for 65% of intake [31]. This can be 
contrasted with the US where vitamin D fortified milk makes by far the highest contribution to intakes 
(58% in men, 39% in women) [40], figures comparable to those of Canada where milk products 
account for 49% of dietary vitamin D intake [36]. In Japan, the major sources of dietary vitamin D Nutrients 2011, 3  1026 
 
intake are fish/shellfish (79%) and eggs (9%) [41], though fish consumption has been shown to 
contribute >90% of vitamin D intake in an elderly Japanese cohort [42].  
People are often reliant on dietary intake of vitamin D to satisfy their requirements, however foods 
naturally rich in vitamin D are few in number and in many cases not widely consumed. Table 1 
illustrates the levels of vitamin D generally found in a number of food sources as reported in food 
consumption databases and in the scientific literature. As can be seen in Table 1, the richest sources 
include fish liver oils, oily fish, egg yolk, and wild mushrooms. However, even in those foods 
considered the richest sources of vitamin D, the levels are highly variable. For example, the content of 
vitamin D in fish can vary significantly both between and within species and according to whether they 
are wild or farmed; the vitamin D content of farmed salmon has been shown to be only approximately 
25% that of wild salmon [43].  
Table 1. Vitamin D content of selected foods. 
Food Vitamin  D  Content  (µg/100 g) 
Fish 
Cod liver oil  210.0 [44]–250.0 [45] 
Salmon, wild (Pacific)  13.1 [45]–24.7 [43] 
Salmon, wild (Atlantic)  5.9 [44] 
Salmon, farmed *  6.0 [43] 
Herring, Baltic, raw  5.7–15.4 [46] 
Kipper fillets, raw  8.0 [44] 
Mackerel, raw  8.8 [44]–16.1 [45] 
Sardines, canned in brine  4.6 [44] 
Tuna, canned in oil  6.7 [45] 
Anchovy, canned in oil  1.7 [45]–3.0 [44] 
Cod  Trace [44]–2.6 [43] 
Sole  Trace [44]–2.8 [45] 
Mushrooms 
† 
Mushrooms, wild edible (Cantharellus tubaeformis)  13.6 [46]–29.8 [47] 
Mushrooms, chanterelle  5.3 [45]–14.2 [48] 
Mushrooms, white button (Agaricus bisporus) 0.2  [45] 
Mushrooms, white button (Agaricus bisporus), UV irradiated  11.9 [49] 
Dairy 
Milk, whole, unfortified  0.1 [45] 
Milk, fortified  1.3 [45]–2.0 [50] 
Cheese, cheddar  0.3 [44]–0.6 [45] 
Yoghurt, plain  0.1 [45] 
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Table 1. Cont. 
Meat and Eggs 
Liver, beef, raw  1.2 [45] 
Beef, rib eye steak, raw  0.1 [45] 
Pork, cured bacon, raw  1.6 [45] 
Ham  0.7 [45]–1.1 [44] 
Chicken, breast, raw  0.1 [45] 
Turkey, slices  2.2 [44] 
Butter 1.5  [45] 
Egg, whole, raw  1.8 [44]–2.05 [45] 
Egg, yolk, raw  4.9 [44]–5.4 [45]
Cereal products 
Breakfast cereals, fortified  2.8–8.3 [44] 
Bread, fortified 
† 3.0  [51] 
* Levels dependent on feed; 
† Vitamin D in the form of vitamin D2. Note: Vitamin D intakes are 
discussed in terms of micrograms (μg) or International Units (IU). In Europe μg are most 
commonly adopted as the measure of vitamin D. In order to convert μg to IU multiply by 40.  
Fortified foods are those to which one or more essential nutrients have been added, whether or not it 
is normally contained in the food, for the purpose of preventing or correcting a demonstrated 
deficiency [52]. Enriched foods are those that have nutrients that were originally lost during processing 
restored and are sometimes considered interchangeably with fortified foods [53]. It is also possible to 
enhance animal products by feeding animals vitamin D supplemented feed, thereby increasing the 
levels of vitamin D present in the edible products. In the current review, unless otherwise stated, we 
will consider animal and non-animal fortified foods, and enriched foods under the umbrella term of 
vitamin D-enhanced foods.  
At present, the number and variety of vitamin D fortified foods available on the market differs 
significantly between countries but most commonly includes milk, breakfast cereals and margarines. 
The relative deficit of vitamin D fortified foods can be partly attributed to the country-specific policies 
on food fortification which are not yet unified. Most individual countries have their own national 
policies, even within Europe, which tend to limit the number or type of foods that can be fortified, as 
will be discussed later in the review. Even in those countries where vitamin D food fortification is 
mandatory, current levels of fortification in permitted foods are likely inadequate to satisfy 
physiological requirements [54]. Furthermore, the small number of foods available is likely to have 
limited impact on population dietary intake. For example, certain population groups are low consumers 
of milk, one of the more commonly fortified foods [40]. As such, whilst it is important that currently 
fortified foods continue to be widely available and consumed, novel methods for producing a wider 
variety of vitamin D-rich foods are also increasingly sought.  
In recent years, evidence has emerged demonstrating viable new methods for enhancement of foods 
with vitamin D. Fungi can produce considerable vitamin D2 levels when exposed to UVB light through 
the conversion of natural ergosterol, the rate depending on the irradiation dose and temperature [55,56]. 
The vitamin D content in these irradiated mushrooms appears relatively stable when refrigerated [57] 
and the retention of vitamin D in mushrooms following cooking and storage has been reported as high, Nutrients 2011, 3  1028 
 
at 86% and greater [46]. Even after 6 years of storage, dried mushrooms appear to retain much of their 
vitamin D content [48]. Success in terms of vitamin D enhancement of animal products has been seen 
with pigs, fish and hens. Increasing the dietary vitamin D3 content of pigs diets can produce meat and 
liver with higher levels of vitamin D3 [58,59]. Similarly, the levels of vitamin D in fish can be 
improved through the feeding of vitamin D3-rich feed, with >10% of the dietary content of vitamin D3 
retrieved in the whole fish [60]. The vitamin D content of eggs can also be safely increased by feeding 
hens vitamin D3-rich diets. The consumption of one of these eggs could provide up to 2.8 μg of 
vitamin D, approximately 3 times that of a typical egg, with scope for increasing this even   
further [61,62]. The preservation of vitamin D3 and 25-hydroxyvitamin D3 in egg yolk after cooking is 
high and only modestly affected by storage, with losses of <10% in both cases [46]. Little work has 
been done on modelling the impact that the widespread introduction of such enhanced foods might 
have on the vitamin D intakes of populations. To assess the potential effectiveness of such eggs in 
increasing vitamin D intakes, we simulated the increase that would result from the consumption of 
enhanced eggs by Irish adults. Based upon current estimated intakes of 112 g of eggs and egg dishes 
per week, the consumption of eggs with a vitamin D content of 2.8 µg versus 1.1 µg (per 60 g egg) 
would result in a weekly population intake of 5.2 µg vitamin D from egg products versus the current 
estimated intake of 2.1 µg. By excluding those people that do not consume egg products, intake 
increases from 4.2 µg to 10.8 µg per week. Further assessment of the potential impact of a range of 
vitamin D enhanced foods on population intakes of this vitamin is certainly warranted. To this end we 
have performed food modelling work which will be discussed in the section examining the regulation 
surrounding the sale of foods enhanced with vitamin D. 
3. Foods Enhanced with Vitamin D  
As outlined above, it is feasible to enhance a variety of foods with vitamin D; however, the 
biological significance of consumption of these foods needs to be assessed. In order to assess the 
efficacy of vitamin D enhanced products in increasing serum 25(OH)D concentration, a number of 
randomized controlled trials (RCTs) have been conducted in recent years. The present review focuses 
on the RCTs which provided at least 10µg of vitamin D2 or D3 each day with foods that were enhanced 
with vitamin D [63–71] (Table 2). A literature search was conducted using the PubMed and Medline 
databases up to May 2011 for studies in the English language. Keywords used included “vitamin D” 
and foods that could be fortified with vitamin D, such as “cheese”, “bread”, “orange juice”, “yogurt”, 
“spreads” and “margarine”, “cereals”, and “mushrooms”. 
In general, the majority of the studies concentrated on markers of bone metabolism as well as 
vitamin D status and as a consequence most analysed serum 25(OH)D, PTH and calcium 
concentration; some included collection of a three day food diary. Most of the interventions were three 
to twelve weeks duration and were performed during winter months, when the cutaneous synthesis of 
vitamin D is low and does not contribute to circulating levels of 25(OH)D. Two out of nine studies had 
a longer duration of twenty-four months. Across the nine studies volunteers were generally healthy, 
representing both genders and age groups ranging from 18 to 87 years (Table 2). 
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Table 2. Change in serum 25(OH)D after intake of foods enhanced with vitamin D. 
Food source  References 
Daily dose (µg) 
vitamin D  
(µg vitamin D/100 g 
product) 
Duration and population  Study groups (product portion) 
Change from 
baseline of 
serum 
25(OH)D (%) 
Fortified milk 
Chee et al., 
2003 [64] 
10 µg 
(2.2 µg/100 g) 
24 months  
50–65 years, postmenopausal females  
n = 200 
1. vitamin D3 + Ca-fortified skimmed milk  
2. Usual diet 
25.0 
# 
4.1 
# 
Daly et al., 
2006 [65] 
20 µg  
(5.0 µg/100 g) 
24 months 
50–87 years, ambulatory community-living 
(male)  
n = 167  
1. Vitamin D3 + Ca-fortified UHT milk, reduced fat 
2. Usual diet 
7.4 
# 
−19.9 
# 
Fortified yogurt 
drink 
Nikooyeh et al., 
2011 [68] 
25 µg  
(5.0 µg/100 g)  
12 weeks, October-March 
30–60 years, diabetic subjects  
(fasting blood glucose ≥126 mg/dL) 
n = 90  
1. Vitamin D3-fortified yogurt drink 
2. Vitamin D3 + Ca-fortified yogurt drink  
3. Plain yogurt drink  
75.0 
67.6 
−10.6 
Fortified cheese 
Johnson et al., 
2005 [66] 
(study 1) 
15 µg 
(17.6 µg/100 g) 
2 winter months  
≥60 years, subjects (total serum cholesterol  
<240 mg/dL) 
n = 110  
1. Vitamin D3-fortified process cheese 
2. Placebo process cheese 
3. No cheese 
−8.7 
10.0 
5.6 
Wagner et al., 
2008 [71] 
100 µg * 
(2083.3 or  
1690.8 µg/100 g) **  
8 weeks, January–April 
18–60 years, healthy subjects  
n = 80 
1.Vitamin D3-fortified regular fat cheddar cheese *** 
2. Vitamin D3-fortified reduced fat cheddar cheese 
3. Vitamin D3 supplement to be taken with food  
4. Vitamin D3 supplement to be taken without food  
5. Placebo regular fat cheddar cheese 
6. Placebo supplement 
128.8 
120.7 
106.5 
111.0 
−7.8 
## 
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Table 2. Cont. 
Fortified orange 
juice 
Tangpricha et al., 
2003 [69]  
(study 2) 
25 µg 
(10.4 µg/100 g) 
12 weeks, commenced in March 
22–60 years, healthy subjects  
n = 30 
1. Vitamin D3 + Ca-fortified orange juice 
2. Placebo Ca-fortified orange juice 
150.0 
45.0 
Biancuzzo et al., 
2010 [63] 
25 µg 
(10.6 µg/100 g) 
11 weeks, commenced in February 
18–79 years, healthy subjects  
n = 105 
1. Vitamin D3 orange juice ^ + placebo capsule 
2. Vitamin D2 orange juice + placebo capsule 
3. Vitamin D3 capsules + placebo orange juice 
4. Vitamin D2 capsules + placebo orange juice 
5. Placebo capsule + placebo orange juice  
71.5 
67.1 
42.9 
65.1 
−8.6 
UV enhanced 
mushrooms 
Urbain et al., 
2011 [70] 
100 µg * 
(191.0 µg/100 g) ** 
3 weeks + 2 weeks follow up, January–March  
Healthy female and male <45 years  
n = 27 
1. Vitamin D2 soup + placebo orange juice ***  
2. Placebo soup + vitamin D2 supplement in orange juice 
3. Placebo soup + placebo orange juice 
50.0 
# 
76.7 
# 
−28.9 
# 
Fortified bread 
Natri et al.,  
2006 [67] 
10 µg 
(27.3 µg/100 g) 
3 weeks, February–March  
25–45 years, healthy females  
(25(OH)D < 58.1 nmol/L) 
n = 41  
1. Vitamin D3-fortified wheat bread (85 g) 
2. Vitamin D3-fortified rye bread  
3. Regular wheat bread + vitamin D3 supplement  
4. Regular wheat bread  
65.0
 ### 
59.0 
### 
78.0 
### 
−1.2 
### 
* equivalent to a daily dose; ** ingested in one weekly dose; *** all portions served once a week; 
# measurement at the end of the intervention; 
## combined placebo 
groups; 
### estimated baseline 25(OH)D; ^ all orange juice in this study contained 350 mg Ca/236.6 mL. 
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In the current literature the most commonly used vehicles for vitamin D fortification are dairy 
products (milk, cheese and yogurt). Two long term studies (24 months) used milk fortified with 
vitamin D3 to deliver 10 µg or greater per day [64,65]. In both studies, 25(OH)D concentrations 
increased for the supplemented group compared to baseline; however, the relative increases varied 
between the studies (25.0% vs. 7.4%) which may be as a result of very different study populations. It 
should be noted that in the study by Daly and colleagues a 20% decrease in serum 25(OH)D was 
reported for the control group. In general, compliance was good, with only a small number of dropouts 
reported despite the necessity to consume a large volume of milk (400 mL/day). Both studies 
concluded that vitamin D was bioavailable and improved 25(OH)D status and markers of bone 
turnover. Similarly, daily intake of 25 µg of vitamin D3 in a yogurt drink with or without added 
calcium significantly increased serum 25(OH)D3 concentrations after 12 weeks by 75.0% and 67.6%, 
respectively, compared to a decrease of 10.6% in the control group. In addition, the glycaemic status in 
diabetic patients was improved [68]. Acceptance of the drink was high among volunteers and no 
adverse effects were observed.  
Fortification of cheese with vitamin D has been examined in two separate eight-week studies 
showing diverse results. In the study by Johnson and colleagues, consumption of fortified cheese   
(15 µg vitamin D) resulted in an 8.7% decrease in their serum 25(OH)D [66]. This was an unexpected 
finding that the authors attribute to a higher baseline value of 25(OH)D in the supplemented group. 
Additionally no changes in serum PTH were found. The second study by Wagner et al. showed an 
approximate 120% increase in serum 25(OH)D concentration after a weekly dose of 700 µg vitamin D 
fortified cheese [71]. In this study serum PTH decreased and there were no changes in serum calcium 
concentration; additionally no dropouts or adverse side effects observed were reported. However, in 
the study by Johnson and colleagues there were five dropouts in the cheese group: the reasons for 
withdrawal included gastrointestinal problems, a dislike for the saltiness of the cheese and medical 
advice [66]. Indeed, as cheese typically contains relatively high levels of salt and saturated fat, a 
portion size closer to that usually recommended for cheese (30 g) rather than what was used by 
Johnson et al. (85 g) may have been more appropriate [66]. Overall, cheese could be a feasible food for 
the improvement of vitamin D status, but a more realistic amount and vitamin D dose should be used 
in future studies. To summarise, vitamin D was bioavailable from all studied dairy products; enhanced 
milk and yogurt or a very high weekly intake of enhanced cheese improved vitamin D status, whilst 
consumption of 15 µg of vitamin D in cheese was insufficient to produce a significant increase in 
serum 25(OH)D.  
Due to lactose intolerance or low dairy product consumption in some countries, new foods should 
be considered as possible vehicles for enhancement with vitamin D. Two RCTs using orange juice 
fortified with 25 µg of vitamin D showed a positive effect on serum 25(OH)D concentration [63,69]. 
In the study of Tangpricha et al., 25(OH)D increased by 150% after 12 weeks supplementation [69]. 
The second study reported that ingestion of 25 µg vitamin D2 and D3 fortified orange juice for   
11 weeks resulted in a rise in serum 25(OH)D concentration by 67.1% and 71.5%, respectively [63]. 
Serum PTH decreased only in the first study, while calcium concentration remained stable in both 
interventions. No adverse effects were reported in either study. The fortification of orange juice with 
vitamin D seems a promising method of boosting serum 25(OH)D concentration. However, replication 
of the above studies using a daily dose in line with the RDA for vitamin D is warranted.  Nutrients 2011, 3  1032 
 
 
Another non-dairy vitamin D enhanced product that has received attention recently is mushrooms. 
Vitamin D2 from wild grown mushrooms was well absorbed and bioavailable in humans [72]. This 
study used wild and not enhanced mushrooms, and therefore has not been included in this review that 
focuses on enhanced vitamin D foods. However, a recent paper has investigated the effect of a weekly 
dose of 700 µg of vitamin D from vitamin D2-enhanced mushrooms in a soup [70] and reported a 50% 
increase in serum 25(OH)D concentration. There were no changes in serum PTH and calcium concentration 
and no adverse effects were observed. Additionally, the soup was well tolerated by volunteers. The 
limitations of this study include the low number of subjects and the high vitamin D dose ingested 
weekly. Nonetheless, this study demonstrated that vitamin D from mushrooms was bioavailable and 
shows promise as an alternative to supplements in maintaining serum 25(OH)D concentration. 
Bread fortified with vitamin D could also serve as a good source of vitamin D due to its common 
consumption. Promising results were obtained following daily consumption of 125 µg of vitamin D3 
enhanced bread for 12 months in older adults [73], however the details of the study are not included  
in Table 2 as it was a single-arm design. To date, only one RCT has investigated the effect of 
supplementation of wheat and rye bread with 10 µg of vitamin D3 per daily 85 g portion (equivalent to 
four thin slices) [67]. In this study serum 25(OH)D increased by approximately 60% after 3 weeks in 
both groups that received fortified bread. No differences in serum PTH were found, while calcium 
concentration decreased in the fortified rye bread group. Three subjects dropped out of the study due to 
difficulties with compliance. In conclusion, fortified bread increased serum 25(OH)D concentration, 
with rye and wheat bread equally effective. 
Finally, the aforementioned RCTs show the potential of a number of vitamin D enhanced foods to 
increase vitamin D status. Overall, fortification was the principal strategy adopted but the potential of 
UV light enhanced mushrooms to boost vitamin D status was more recently explored. A comparison 
between the studies is difficult to perform because of variability in the population characteristics   
(i.e., age, gender), dose of vitamin D provided, intervention period and methods used for 25(OH)D 
determination [74,75]. The majority of the studies provided a daily supply of the foods whilst two used 
a weekly dose. However, the impact of the frequency of dose has not been studied in relation to any of 
the above foods. With respect to intake of vitamin D supplements it has been demonstrated that the 
frequency of intake has an impact on 25(OH)D serum concentrations [76], illustrating the imperative 
need to study this in the vitamin D enhanced foods. Overall, in the enhanced food a higher dose was 
more effective in increasing 25(OH)D concentration; however, for short term studies (3 weeks) the 
increase seemed to be independent of dose. The majority of the foods in the selected RCTs were well 
tolerated by the study subjects. After the ingestion of different vitamin D fortified/enriched foods, PTH 
decreased or did not change, while serum calcium concentration remained stable or in the case of the 
rye bread group decreased, highlighting no safety risks with the use of these vitamin D enhanced 
products. Milk, yogurt, orange juice, mushrooms and bread proved to be good matrices for 
supplementation with vitamin D at the level of 10 µg (milk, bread), 25 µg (orange juice and yogurt) or 
or 100 µg (mushrooms). More studies are needed to assess the effectiveness of vitamin D fortified 
cheese, with the use of a more feasible serving size. Finally, more RCTs, using these foods, should be 
conducted to investigate the link between vitamin D and other disease markers beyond those related to 
bone health and vitamin D status. 
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4. Vitamin D2 and D3 Bioavailability 
Until relatively recently it was widely believed, based upon anti-rachitic findings, that vitamin D2 
and D3 were equipotent and could be considered interchangeably. However, evidence is accumulating 
to suggest the two forms may vary in their bioefficacy and the importance of this must be considered 
when discussing potential food matrices. A number of recent studies addressing the potency of the  
two calciferols have found D3 to be more effective in raising serum 25(OH)D levels. In a group of 
vitamin D insufficient hip fracture patients, a daily capsule of 25 µg D3 was more effective than an 
equal dose of D2 in increasing total serum 25(OH)D [77]. Also in older populations, 15 µg daily or 
1250 µg monthly of capsular vitamin D3 increased serum 25(OH)D more efficiently than an equal dose 
of D2 [78], as has also been shown with a single 7500 µg dose of oral or intramuscular D3 [79]. The 
increased ability of a weekly capsule of 1250 µg of D3 for 12 weeks to maintain serum 25(OH)D when 
compared with equimolar D2 has also been shown in healthy adults [80]. These findings support those 
of a number of earlier studies also addressing this topic [81,82].  
The above findings were not replicated in a number of recent studies in which D2 and D3 were 
found to be equally effective in increasing serum 25(OH)D when administered to healthy adults as 
capsules [63,83] or in orange juice [63] for 11 weeks, or in a high-dose liquid suspension to vitamin D 
deficient infants for 6 weeks [84]. Despite this, the general consensus that is beginning to emerge is 
that vitamin D3 is the more potent form. However, it is difficult to directly compare the results of the 
discussed studies given the many confounding factors between them. Most notable in this regard are 
the different methods employed to analyze serum 25(OH)D, the differing baseline serum levels, the 
variance in age groups studied, the doses administered, and the duration of supplementation. Overall, 
more studies specifically designed to address this question are needed before the results can be 
translated into a public health message. 
5. Regulation Surrounding the Sale of Foods Enhanced with Vitamin D 
From a regulatory perspective, the vitamin D enhanced foods mentioned in this review have 
typically fallen into two categories (i) fortified foods and (ii) foods that have used technologies to 
enhance naturally occurring vitamin D levels. However, prior to sale on a commercial scale, there are a 
series of steps which potential manufacturers must consider. Globally these can vary depending on the 
region (e.g., Europe, US) and also between countries (e.g., with respect to fortification policies). This 
review will now briefly outline some of the regulations that must be considered in the EU.  
For fortified foods, addition of both ergocalciferol and cholecalciferol is permitted but consideration 
must be given to dietary intake from other sources and safe upper levels of intake before agreeing on 
the levels of addition [85]. At present the IOM has defined 100 μg/day as an upper level for vitamin D 
intake [29]. Regarding foods which exploit new technologies to enhance naturally occurring levels  
(as in the case of vitamin D enhanced mushrooms, which were irradiated by UV light), if they are not 
currently widely consumed within the EU, they would be considered as a “novel food” and subject to 
approval as “safe for use” by the competent authority in the applicant country and also in other 
Member States [86]. Nutrients 2011, 3  1034 
 
 
Thereafter, both categories of food are subject to general food law labelling. Currently, in the EU 
vitamins and minerals can be declared on food only if they are present in a “significant” amount,  
i.e., ≥15% of Recommended Daily Allowance (RDA) [87]. According to current legislation in relation 
to vitamin D, food containing ≥0.75 µg vitamin D/100 g (100 mL) product can be claimed as a 
“source” of vitamin D, whereas to be declared as “high” in vitamin D, it has to contain at least twice 
the value of a “source” of vitamin D, i.e., ≥1.5 µg/100 g (100 mL) or 30% RDA [88,89]. For those 
manufacturers who wish to make further nutrition and health claims, specific procedures and 
conditions for use are applicable to each claim and are outlined in the appropriate regulations [88]. In 
brief, there are three categories of permitted health claims (i) article 13 general function claims;   
(ii) article 13.5 claims based on newly developed scientific evidence; and (iii) article 14 claims 
referring to the reduction of a risk factor in the development of a disease and children’s development 
and health. Currently, approved vitamin D health claims relate to vitamin D and bone and teeth health, 
absorption and utilisation of calcium and phosphorus, normal function of the immune system, cell 
division, normal growth and development of bone in children, as well as claims referring to the 
relationship between calcium and vitamin D and the reduction of bone loss in elderly women [90–94]. 
However, if a vitamin D-enhanced product wishes to bear any of the above claims, it must conform to 
the aforementioned conditions for use and to as yet unspecified nutrient profiles [87,88]. 
As mentioned, we conducted food modelling to simulate the intake of vitamin D from enhanced 
foods in the Irish adult population. Initially the effect of consumption of orange juice enhanced with 
10.5 µg vitamin D per 100 g on mean daily intakes was investigated. Consumption of such orange 
juice would increase mean intakes of vitamin D from 4.7 µg to 7.9 µg per day. In another simulation 
designed to mimic mandatory fortification policies, in tandem with the orange juice, milk was 
enhanced at a conservative level of 1 µg/100 g. In this scenario intakes increased to 9.9 µg/day, 
however, it also resulted in 1% of the population consuming >50 µg vitamin D, thereby reiterating the 
need to be cognisant of extreme consumers. On the other hand, any mandatory fortification policies 
would need to be aware of non-consumers of the particular enhanced food group: to this end it may be 
prudent to introduce fortification at low levels in a number of foods.  
6. Conclusions 
Overall, the evidence that enhanced vitamin D foods can improve vitamin D status is convincing. A 
range of enhanced foods were shown to be effective in increasing circulating 25(OH)D concentrations 
with no signs of adverse effects. Further research and development in such foods is warranted as they 
have the potential to provide a means to address the vitamin D deficiency pandemic. 
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